Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites.
Rincón D, Vaquero J, Hernando A, Galindo E, Ripoll C, Puerto M, Salcedo M, Francés R, Matilla A, Catalina MV, Clemente G, Such J, Bañares R.
Rincón D, et al. Among authors: matilla a.
Liver Int. 2014 Nov;34(10):1504-12. doi: 10.1111/liv.12539. Epub 2014 Apr 4.
Liver Int. 2014.
PMID: 24661740
Clinical Trial.